CD19 and B-cell chronic lymphocytic leukemia: Using the Eμ-TCL1 mouse model, which is the most widely used animal model to study pathophysiology, clonal evolution and drug sensitivity in CLL (17–19), we could characterize that CD5+CD19+ leukemic cells from Eμ-TCL1 transgenic mice possess many important features of anergic CLL cells.